Identification and prediction of common molecular culprits between psoriasis and melanoma via bioinformatical analysis

[1]  Xiaoli Zheng,et al.  Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma , 2020, Frontiers in Oncology.

[2]  Wenxing Su,et al.  Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis , 2020, BMC cancer.

[3]  D. Su,et al.  Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression , 2019, BMC Cancer.

[4]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[5]  Adriana Rendon,et al.  Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.

[6]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[7]  Carola Berking,et al.  Melanoma , 2018, The Lancet.

[8]  R. Nibbs,et al.  A guide to chemokines and their receptors , 2018, The FEBS journal.

[9]  Hideo Baba,et al.  CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. , 2018, Cancer treatment reviews.

[10]  P. Proost,et al.  Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands , 2018, Front. Immunol..

[11]  M A Weinstock,et al.  Epidemiology of melanoma. , 2017, Cancer treatment and research.

[12]  H. Shukla,et al.  Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer , 2017, Proteomes.

[13]  Jashin J. Wu,et al.  The risk of melanoma and hematologic cancers in patients with psoriasis , 2017, Journal of the American Academy of Dermatology.

[14]  S. John,et al.  A systematic review of worldwide epidemiology of psoriasis , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  D. Glass,et al.  Genetic epidemiology of melanoma , 2016, European Journal of Dermatology.

[16]  Q. Lu,et al.  The Inflammatory Response in Psoriasis: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.

[17]  W. Boehncke.  Etiology and Pathogenesis of Psoriasis. , 2015, Rheumatic diseases clinics of North America.

[18]  K. Sayama,et al.  CCL27 Is Downregulated by Interferon Gamma via Epidermal Growth Factor Receptor in Normal Human Epidermal Keratinocytes , 2014, Journal of cellular physiology.

[19]  A. Pellín,et al.  CCL27–CCR10 and CXCL12–CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma , 2012, Clinical & Experimental Metastasis.

[20]  Yan Shi,et al.  Toll-Like Receptors: Role in Dermatological Disease , 2010, Mediators of inflammation.

[21]  James T. Elder.  Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese , 2009, Genes and Immunity.

[22]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[23]  James T. Elder,et al.  Genetics of psoriasis and psoriatic arthritis: update and future direction. , 2008, The Journal of rheumatology.

[24]  L. Dubertret,et al.  Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. , 2007, European journal of dermatology : EJD.

[25]  Shinichi Watanabe,et al.  Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. , 2007, Endocrinology.

[26]  R. Modlin,et al.  The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. , 2005, The Journal of investigative dermatology.

[27]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[28]  Koichiro Nakamura,et al.  Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. , 2003, The Journal of allergy and clinical immunology.

[29]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[30]  L. Cornelius,et al.  The role of chemokines in melanoma tumor growth and metastasis. , 2002, The Journal of investigative dermatology.

[31]  E. Christophers.  Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[32]  T. Mabuchi,et al.  Chemokine receptors in the pathogenesis and therapy of psoriasis. , 2012, Journal of dermatological science.

[33]  J. Hornaday,et al.  Cancer Facts & Figures 2004 , 2004 .

[34]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..